Pharmaceuticals and Biotechnology Co-promotion and Co-marketing Partnering Trends Report 2024: Analysis of Deals Signed by the World’s Leading Life Science Companies Signed Since 2016

DUBLIN, March 7, 2024 /PRNewswire/ — The “Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2024” report has been added to ResearchAndMarkets.com’s offering.

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals.

Fully revised and updated, the report provides details of co-promotion and co-marketing deals from 2016 to 2024, the report provides access to co-promotion and co-marketing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of co-promotion and co-marketing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in co-promotion and co-marketing as well as a discussion on the merits of the type of deal. Chapter 3 provides an overview of the structure of co-promotion and co-marketing deals.

Chapter 4 provides a review of the leading co-promotion and co-marketing deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database. Chapter 5 provides a comprehensive listing of the top 25 most active co-promotion and co-marketing dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of co-promotion and co-marketing deals organized by company A-Z, therapy, technology and industry type signed and announced since 2016 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the co-promotion and co-marketing deal.

The deal directory includes a comprehensive listing of all co-promotion and co-marketing deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in co-promotion and co-marketing dealmaking since 2016. In conclusion, this report provides everything a prospective dealmaker needs to know about co-promotion and co-marketing alliances.

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

Understand deal trends since 2016Browse co-promotion and co-marketing dealsBenchmark analysis – identify market value of transactionsFinancials termsDirectory of deals by company A-Z, therapy focus and technology typeLeading deals by valueMost active dealmakersIdentify assets and deal terms for each transactionAccess contract documents – insights into deal structuresDue diligence – assess suitability of your proposed deal terms for partner companiesSave hundreds of hours of research time

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology includes:

Trends in co-promotion and co-marketing dealmaking in the biopharma industryOverview of co-promotion and co-marketing deal structureDirectory of co-promotion and co-marketing deal records covering pharmaceutical and biotechnologyThe leading co-promotion and co-marketing deals by valueMost active co-promotion and co-marketing dealmakersThe leading co-promotion and co-marketing partnering resources

Analyzing contract agreements allows due diligence of:

What are the rights granted or optioned?What rights are granted by the agreement?What exclusivity is granted?What is the payment structure for the deal?How are sales and payments audited?What is the deal term?How are the key terms of the agreement defined?How are intellectual property rights handled and owned?Who is responsible for commercialization?Who is responsible for development, supply, and manufacture?How is confidentiality and publication managed?How are disputes resolved?Under what conditions can the deal be terminated?What happens when there is a change of ownership?What sublicensing and subcontracting provisions have been agreed?Which boilerplate clauses does the company insist upon?Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in co-promotion and co-marketing dealmaking
2.1. Introduction
2.2. Definition of co-promotion and co-marketing deals
2.3. Trends in co-promotion and co-marketing deals since 2016
2.3.1. Co-promotion and co-marketing dealmaking by year, 2016-2024
2.3.2. Co-promotion and co-marketing dealmaking by phase of development, 2016-2024
2.3.3. Co-promotion and co-marketing dealmaking by industry sector, 2016-2024
2.3.4. Co-promotion and co-marketing dealmaking by therapy area, 2016-2024
2.3.5. Co-promotion and co-marketing dealmaking by technology type, 2016-2024
2.3.6. Co-promotion and co-marketing dealmaking by most active company, 2016-2024
2.4. Reasons for entering into co-promotion and co-marketing partnering deals
2.5. The future of co-promotion and co-marketing deals

Chapter 3 – Overview of co-promotion and co-marketing deal structure
3.1. Introduction
3.2. Co-promotion and co-marketing agreement structure

Chapter 4 – Leading co-promotion and co-marketing deals
4.1. Introduction
4.2. Top co-promotion and co-marketing deals by value

Chapter 5 – Top 25 most active co-promotion and co-marketing dealmakers
5.1. Introduction
5.2. Top 25 most active co-promotion and co-marketing dealmakers

Chapter 6 – Co-promotion and co-marketing deals including contracts directory
6.1. Introduction
6.2. Co-promotion and co-marketing deals with contracts 2016-2024

Deal directory

Deal directory – Co-promotion and co-marketing dealmaking by companies A-ZDeal directory – Co-promotion and co-marketing dealmaking by therapy areaDeal directory – Co-promotion and co-marketing dealmaking by technology type

Some of the companies featured

3D Medicines4D Molecular TherapeuticsAbbvieAbCellera BiologicsALK-AbelloAllegis PharmaceuticalsAllerganBausch & LombBaxaltaBayerBeam TherapeuticsBeiGeneBeijing Minhai BiotechnologyBelharra TherapeuticsBelintraBerlin ChemieBioAge LabsBiogenBiognosysBiological IndustriesBioNano GenomicsBioNTechCipher PharmaceuticalsConcordia PharmaceuticalsCRISPR TherapeuticsCrossLink BioscienceCSLDova PharmaceuticalsDovetail GenomicsDualityBioEagle GenomicsEagle PharmaceuticalsEA PharmaEli LillyEmpaticaEnterome BioscienceEpizymeEton PharmaceuticalsExact SciencesFabric GenomicsGilead SciencesGlenmark PharmaceuticalsGoldfinch BioGSKGT ResearchH3 BiomedicineHalyard HealthHanmi PharmaceuticalHarbin Pharmaceutical GroupHD BiosciencesIconic TherapeuticsIdorsiaIGM BiosciencesIlluminaImmatics BiotechnologiesImmuniconImmunityBioIonis PharmaceuticalsIronwood PharmaceuticalsiTeos TherapeuticsJanssen BiotechJanssen PharmaceuticalsJiangsu AlphamabKonica MinoltaKowa Pharmaceuticals AmericaKSQ TherapeuticsKyorin PharmaceuticalKyowa Hakko KirinKyverna TherapeuticsLuqa PharmaceuticalsLuxcel BiosciencesLygosMacrogenicsManchester BIOGELMannKind BiopharmaceuticalsMedicines360MedImmuneMedovateMEI PharmaMenariniMerck and CoMerck KGaAMersana TherapeuticsMesoblastMetagenomiMetavantMicrosoftNkarta TherapeuticsNovartisNovo NordisknRichDXNumabOtonomyOtsukaOxford BioMedicaPacira BiosciencesParagon BioservicesPfizerPhilProthenaProvention BioPSI (Population Services International)Purdue PharmaPure PharmaceuticalsQED TherapeuticsQiagenQuantaRadius HealthRainbow ScientificRakuten MedicalRecludix PharmaRedHill BiopharmaRefleXion MedicalRegeneron PharmaceuticalsRegenxbioRelay TherapeuticsRepare TherapeuticsResonant Specific TechnologiesRevolution MedicinesRigel PharmaceuticalsRocheSanofiSeren PharmaceuticalsSeres TherapeuticsShimadzuShionogiSilicon BiosystemsSimcere PharmaceuticalsSirtex MedicalSK BiopharmaceuticalsSolid BiosciencesSonoma BioTherapeuticsSoseiSparingVisionStealth BioTherapeuticsStoke TherapeuticsStrideBioTango TherapeuticsTeijinTelix PharmaceuticalsTerumo Blood and Cell TechnologiesTetraphase PharmaceuticalsTeva Pharmaceutical IndustriesTheravanceThermo Fisher ScientificTilak HealthcareTilrayTitan PharmaceuticalsTolmarUrovant SciencesUS WorldMedsVerity PharmaceuticalsVertex PharmaceuticalsVertice PharmaVifor PharmaVoyager TherapeuticsWAVE Life SciencesXellia PharmaceuticalsXencorZAI LaboratoryZymeworks

For more information about this report visit https://www.researchandmarkets.com/r/dw3ldi

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/pharmaceuticals-and-biotechnology-co-promotion-and-co-marketing-partnering-trends-report-2024-analysis-of-deals-signed-by-the-worlds-leading-life-science-companies-signed-since-2016-302082755.html

SOURCE Research and Markets